Predictive biomarkers for low-dose IL-2 therapy efficacy in systemic lupus erythematosus: a clinical analysis
These findings uncovered the predictors of Ld-IL2 treatment efficacy in SLE patients and provided guidance to physicians for rational utilization.
Authors
- Ruiling Feng (ORCID: https://orcid.org/0000-0003-1465-3259)
- Zhanguo Li (ORCID: https://orcid.org/0000-0002-2590-6242)
- Xian Xiao (ORCID: https://orcid.org/0009-0007-2718-4371)
- Xia Zhang (ORCID: https://orcid.org/0000-0001-5671-633X)
- Jing He (ORCID: https://orcid.org/0000-0003-3904-8928)
- Yuan Jia (ORCID: https://orcid.org/0000-0002-7928-3917)
- Bo Huang (ORCID: https://orcid.org/0000-0001-7811-898X)
- Kai Zhang (ORCID: https://orcid.org/0000-0001-6818-377X)
Institutions
- Peking University (CN)
- Peking University People's Hospital (CN)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2024-10-22
- DOI
- https://doi.org/10.1186/s13075-024-03388-5
- Citations
- 5
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 2.35
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Beijing Science and Technology Planning Project